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ABSTRACT
Gastric surgery is one of the most relevant ﬁ elds of development for minimally invasive 
technologies. Laparoscopy is now widespread, and several studies have demonstrated 
its feasibility and safety even in some advanced oncological procedures. Robotic 
surgery has several intrinsic advantages that theoretically can improve an extensive 
lymphadenectomy or the reconstruction phase.
Much remains to be addressed in this ﬁ eld and further studies are necessary to oﬀ er 
the patient the best possible approach based on his characteristics and the stage of his 
disease.
The present report oﬀ ers an overview on robotics and its role in gastric surgery.
© The Author(s) 2019. Published by ED Marketing & Communication. All rights reserved.
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Background
Robotic technology has spread throughout the world 
in the last decades and Italy has been one of the À rst 
countries introducing robotic systems in Europe. 
In recent years the number of procedures has 
dramatically increased. 
Over 86 robotic systems are currently active, and the 
number of procedures is now over 13,000 operations per 
year. Therefore, nowadays, Italy together with France 
is the À rst country in Europe for the total number of 
robotic surgical procedures performed per year.
Robotic technology has revolutionized our approach to 
minimally invasive surgery. 
In this context, many À elds of interest are currently 
under development: new devices and platforms, 
imaging integrated technology, teaching opportunities, 
new techniques.
The Xi robot represents the 4th generation of the Da 
Vinci systems and the evolution of the previous Si 
version. Moreover, new devices have been produced 
with instruments even more advanced. For example, the 
endowristed robotic stapler that allows the surgeon to 
sectioning by a correct angle of vision from the console. 
The vessel sealer uses advanced radiofrequency energy 
and could be particularly useful for liver parenchyma 
transection.
Then, the single site surgery could open the possibility 
for new applications even for gastric surgery.
Today the Xi system offers the possibility of combining 
images from different sources. For example, it’s possible 
to perform an intraoperative ultrasound or follow a 
gastroscopy, from the robotic console, together with 
the 3D view of the operative À eld. These developments 
are improving and changing the way we perform 
oncological surgical procedures and new concepts of 
surgery are now emerging: the navigation surgery and 
the targeted surgery[1].
Robotic technology represents also a huge opportunity 
for education. Young surgeons can perform different 
surgical steps of complex procedures through mentoring. 
Robotic simulators are also available. 
So, training in robotic surgery can start at the simulator 
and then go through the execution of different surgical 
steps from the easier to the challenging ones, and À nally 
approach the entire operation.
Robotic gastric surgery
Certainly, oncologic gastric surgery is one of the areas 
of greatest interest and development in the À eld of 
minimally invasive and robotic surgery[2-4].
Many centers have published their own experiences[5] 
and comparative studies, giving authors of systematic 
reviews and meta-analysis the opportunity to try to 
deÀ ne the role of robotic surgery by comparing it with 
traditional laparoscopy or open surgery. However, 
the current level of evidence is far from being able to 
consider these procedures in common surgical practice. 
Current guidelines describe laparoscopy as a possible 
alternative to open surgery for early gastric cancer, while 
robotic surgery is recognized to have some advantages, 
but this approach is not mentioned in gastric cancer 
guidelines[6].
The main discussed limitations are the proper execution 
of an extended lymphadenectomy, when required, and 
a safe approach for reconstruction. The latter is still the 
object of controversy and most surgeons are concerned 
about the possibility to perform a totally intracorporeal 
procedure.
Face the reconstruction with new approaches: the 
Parisi’s Technique
The technique we have developed for reconstruction after 
total gastrectomy is called “double loop method”[7-9] 
in which a À rst loop of bowel is measured and shifted 
up antecolic to directly perform the esophago-jejunal 
anastomosis. The jejunal loop is secured to the posterior 
wall of the esophagus with seromuscular interrupted 
stitches (second posterior layer of the anastomosis). 
The row of metallic stitches at the esophagus margin 
is removed and a 3 cm incision is made at the jejunum 
side. A double continuous suturing is performed with 
PDS 3/0. The anastomosis is completed with a second 
anterior layer performed with interrupted stitches.
The second loop (alimentary limb) is measured up to 40 
cm starting from the esophago-jejunostomy and is À xed 
to the biliary limb close to the previous anastomosis on 
its left side.
A jejuno-jejunal anastomosis is now performed as usual.
Finally, the two anastomoses are interrupted by À ring 
the linear stapler. 
Preliminary results of this approach were previously 
reported[7, 9].The double loop method increases 
the feasibility of a full hand-sewn intracorporeal 
reconstruction.
Robotic Gastrectomy in Italy: IMIGASTRIC data
We have looked to the data collected in the IMIGASTRIC 
database[10-13] and we extracted those patients who 
underwent robotic surgery in Italian Institutions to 
show their characteristics and outcomes.
Overall data of 222 patients were found. The average 
age was 68yo, BMI around 25, 50% of patients had 
comorbidities. At the pathology examination 56% 
of cases were Advanced Gastric Cancer, most with 
undifferentiated histology. Majority of patients, 74%, 
underwent a distal gastrectomy.
Among the intraoperative outcomes, mean EBL was 
137ml, a low rate of intraoperative complications 
occurred, there were no major intraoperative 
complications or death.
Overall, during the postoperative course, patients 
underwent mobilization on the 1 postoperative day, the 
liquid diet was administered at the 3 POD and a soft solid 
diet on the 4 POD. Intravenous analgesics were used for 
an average of 3 days. Mean hospital stay resulted 8 days.
16% of patients experienced medical or surgical related 
postoperative complications. The majority were low-
grade complications (CD I+II), while only 5 patients (2%) 
had major complications requiring a reoperation. 4% 
of patients were readmitted after discharge. No death 
occurred. Among surgical complications, 6 patients had 
leakages (leakage rate 2,7%) but only one underwent 
reoperation.
Conclusion
Despite the potential beneÀ ts of robotic surgery, there 
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is still a lot of research to be done in this À eld and the 
scientiÀ c community is asking what strategies need to 
be adopted in future studies to develop and standardize 
minimally invasive surgery.
That’s why, 3 years ago, we have established a multi-
institutional cooperation with a project aimed to collect 
eastern and western data in a large registry, called 
IMIGASTRIC. A network is today needed to bring 
together different experiences and institutions with the 
aim of improving medical and surgical care in gastric 
cancer patients.
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